Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jun;5(6):313-8.
doi: 10.1038/nrneph.2009.67. Epub 2009 Apr 28.

ANCA-negative pauci-immune crescentic glomerulonephritis

Affiliations
Review

ANCA-negative pauci-immune crescentic glomerulonephritis

Min Chen et al. Nat Rev Nephrol. 2009 Jun.

Abstract

Crescentic glomerulonephritis is a severe form of glomerular injury that is characterized by disruption of the glomerular basement membrane, cellular proliferation within Bowman space, and (often) fibrinoid necrosis. Pauci-immune crescentic glomerulonephritis, so called because it involves little or no glomerular immunoglobulin deposition, is one of the most common causes of rapidly progressive glomerulonephritis. In the majority of patients, pauci-immune crescentic glomerulonephritis is a manifestation of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. However, some patients with pauci-immune crescentic glomerulonephritis lack ANCAs. This Review compares the prevalence, clinical manifestations, histopathology, and outcomes of ANCA-negative pauci-immune crescentic glomerulonephritis with those of ANCA-positive disease. We also discuss the possible pathogenesis of ANCA-negative pauci-immune crescentic glomerulonephritis, paying particular attention to the mechanisms and role of neutrophil activation.

PubMed Disclaimer

References

    1. Nat Med. 2008 Oct;14(10):1088-96 - PubMed
    1. Am J Kidney Dis. 1998 Jul;32(1):179-84 - PubMed
    1. Clin Exp Immunol. 1994 Nov;98(2):270-8 - PubMed
    1. Am J Clin Pathol. 1986 Sep;86(3):274-80 - PubMed
    1. Clin Exp Immunol. 1997 Dec;110(3):403-9 - PubMed

Publication types

MeSH terms

Substances